Recombinant EGFL7 (Parsatuzumab Biosimilar) antibody

Catalog No. ABIN7676042

The Human Monoclonal anti-EGFL7 (Parsatuzumab Biosimilar) antibody is suitable to detect EGFL7 (Parsatuzumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant EGFL7 (Parsatuzumab Biosimilar) antibody (ABIN7676042)

Target: EGFL7 (Parsatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This EGFL7 (Parsatuzumab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-EGFL7 (Parsatuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-EGFL7 Reference Antibody (parsatuzumab)

Characteristics: Anti-EGFL7 Reference Antibody (parsatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for EGFL7 (Parsatuzumab Biosimilar)

Target: EGFL7 (Parsatuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q9UHF1